COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 3030: Articles 30291-30300  | Next

Assessment of public attention, risk perception, emotional and behavioural responses to the COVID-19 outbreak: social media surveillance in China
Hou, Z., Du, F., Jiang, H., Zhou, X., Lin, L.
10.1101/2020.03.14.20035956 — Posted: 2020-03-17
Expected impact of COVID-19 outbreak in a major metropolitan area in Brazil
Rocha Filho, T. M., Ganem dos Santos, F. S., Gomes, V. B., Rocha, T. A. H., Croda, J. H. R., Ramalho, W. M., Araujo, W. N.
10.1101/2020.03.14.20035873 — Posted: 2020-03-17
Excess cases of Influenza like illnesses in France synchronous with COVID19 invasion.
BOELLE, P.-Y., Sentinelles syndromic and viral surveillance group
10.1101/2020.03.14.20035741 — Posted: 2020-03-17
Epidemiological Trends of Coronavirus Disease 2019 in China
Lin, B., Zhong, H., Ni, Y., Liu, L., Zhong, J., Su, X.
10.1101/2020.03.13.20035642 — Posted: 2020-03-17
Multi-city modeling of epidemics using spatial networks: Application to 2019-nCov (COVID-19) coronavirus in India
Pujari, B. S., Shekatkar, S. M.
10.1101/2020.03.13.20035386 — Posted: 2020-03-17
Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study
Zhao, W., Yu, S., Zha, X., Wang, N., Pang, Q., Li, T., Li, A.
10.1101/2020.03.13.20035436 — Posted: 2020-03-17
Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19
Huang, L., Shi, Y., Gong, B., Jiang, L., Liu, X., Yang, J., Tang, J., You, C., Jiang, Q., Long, B., Zeng, T., Luo, M., Zeng, F., Zeng, F., Wang, S., Yang, X., Yang, Z.
10.1101/2020.03.15.20033472 — Posted: 2020-03-17 Discussion: Onsite | Offsite
Temporal relationship between outbound traffic from Wuhan and the 2019 coronavirus disease (COVID-19) incidence in China
Shi, Z., Fang, Y.
10.1101/2020.03.15.20034199 — Posted: 2020-03-17
Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases
Verelst, F., Kuylen, E. J., Beutels, P.
10.1101/2020.03.14.20035980 — Posted: 2020-03-17
International expansion of a novel SARS-CoV-2 mutant
Wang, M., Li, M., Ren, R., Brave, A., Werf, S. v. d., Chen, E.-Q., Zong, Z., Li, W., Ying, B.
10.1101/2020.03.15.20035204 — Posted: 2020-03-17 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).